07 Mar 2018 - Regenerative medical company Mesoblast (ASX:MSB) has entered into a $75 million non-dilutive four year credit facility with Hercules Capital.
This exclusive 48-hour opportunity is available only to DealRoom members.
Sign up now to access the deal - and get early access to future offerings.
401 views
SUMMARY
07 Mar 2018 - Regenerative medical company Mesoblast (ASX:MSB) has entered into a $75 million non-dilutive four year credit facility with Hercules Capital.
POST YOUR COMMENT
COMMENTS